Related Experiment Video

Updated: Jun 24, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Clinical impact of antibiotic-resistant Gram-positive pathogens

H M Lode1

  • 1Research Centre for Medical Studies, Affiliated Institute for Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Berlin, Germany. haloheck@zedat.fu-berlin.de

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|April 2, 2009
PubMed

Insights

Antibiotic resistance in Gram-positive bacteria increases patient mortality and healthcare costs. New strategies are crucial to combat resistant pathogens like MRSA and VRE.

Area of Science:

  • Clinical microbiology and infectious diseases
  • Antimicrobial resistance
  • Public health

Background:

  • Despite a decade of European Union focus, antibacterial resistance rates continue to rise in both Gram-positive and Gram-negative bacteria.
  • Antibiotic-resistant Gram-positive pathogens pose a significant and growing threat to patient health and healthcare systems.

Purpose of the Study:

  • To review and synthesize the clinical impact of antibiotic-resistant Gram-positive bacteria on patient outcomes.
  • To highlight the consequences of infections caused by multidrug-resistant Gram-positive pathogens.

Main Methods:

  • Literature review focusing on clinical studies and data concerning antibiotic-resistant Gram-positive infections.
  • Analysis of outcomes such as mortality, length of hospital stay, and treatment costs associated with resistant strains.

Main Results:

  • Multidrug resistance in pneumococcal infections leads to increased treatment failures and mortality.
  • Methicillin-resistant Staphylococcus aureus (MRSA) infections are associated with higher mortality, prolonged hospital stays, and increased costs compared to methicillin-susceptible strains.
  • Vancomycin-resistant enterococci (VRE) bloodstream infections negatively impact mortality, hospital stay duration, and costs relative to vancomycin-susceptible strains.

Conclusions:

  • Antibiotic resistance in Gram-positive bacteria significantly worsens clinical outcomes for patients.
  • Effective prophylactic and therapeutic strategies are essential to mitigate the clinical consequences of Gram-positive bacterial resistance.
  • Addressing antibiotic resistance requires a multifaceted approach to prevent severe patient outcomes.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...